Retifanlimab and Ruxolitinib In Solid Malignancies
Clinical trial NCT07219576 · RECRUITING
Trial details
- NCT number
- NCT07219576
- Sponsor
- University of California, San Diego
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-08
- Primary completion
- 2027-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.